173 related articles for article (PubMed ID: 2870740)
1. Extracellular hydrolysis of formyl peptides and subsequent uptake of liberated amino acids by alveolar macrophages.
Basilion JP; Stickle DF; Holian A
Biochim Biophys Acta; 1986 Apr; 886(2):255-66. PubMed ID: 2870740
[TBL] [Abstract][Full Text] [Related]
2. Extensive hydrolysis of N-formyl-L-methionyl-L-leucyl-L-[3H] phenylalanine by human polymorphonuclear leukocytes. A potential mechanism for modulation of the chemoattractant signal.
Yuli I; Snyderman R
J Biol Chem; 1986 Apr; 261(11):4902-8. PubMed ID: 3957916
[TBL] [Abstract][Full Text] [Related]
3. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
4. Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.
Marasco WA; Feltner DE; Ward PA
J Cell Biochem; 1985; 27(4):359-75. PubMed ID: 2987275
[TBL] [Abstract][Full Text] [Related]
5. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
Mackin WM; Huang CK; Becker EL
J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
[TBL] [Abstract][Full Text] [Related]
6. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
[TBL] [Abstract][Full Text] [Related]
7. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
[TBL] [Abstract][Full Text] [Related]
8. Absence of FMLP receptors on rat macrophages.
Walker BA; Seiler AJ; Owens CA; Hagenlocker BE; Ward PA
J Leukoc Biol; 1991 Dec; 50(6):600-6. PubMed ID: 1658174
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.
Atkinson YH; Lopez AF; Marasco WA; Lucas CM; Wong GG; Burns GF; Vadas MA
Immunology; 1988 Jul; 64(3):519-25. PubMed ID: 2842255
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of a formyl peptide receptor on lung macrophages: correlation of binding properties with chemotaxis and release of superoxide anion.
Daniele RP; Diamond MS; Holian A
Am Rev Respir Dis; 1982 Aug; 126(2):274-80. PubMed ID: 6285786
[No Abstract] [Full Text] [Related]
11. Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression.
Zimmerli W; Seligmann B; Gallin JI
J Clin Invest; 1986 Mar; 77(3):925-33. PubMed ID: 3005369
[TBL] [Abstract][Full Text] [Related]
12. Calcium regulation of phosphatidyl inositol turnover in macrophage activation by formyl peptides.
Holian A; Stickle DF
J Cell Physiol; 1985 Apr; 123(1):39-45. PubMed ID: 2982888
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
Marasco WA; Fantone JC; Freer RJ; Ward PA
Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
[TBL] [Abstract][Full Text] [Related]
14. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist.
Johansson B; Wymann MP; Holmgren-Peterson K; Magnusson KE
J Cell Biol; 1993 Jun; 121(6):1281-9. PubMed ID: 8509449
[TBL] [Abstract][Full Text] [Related]
15. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production.
Spilberg I; Mehta J; Daughaday C; Simchowitz L
J Lab Clin Med; 1981 May; 97(5):602-9. PubMed ID: 6260878
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils.
Kermode JC; Muthukumaraswamy N; Freer RJ
J Leukoc Biol; 1988 May; 43(5):420-8. PubMed ID: 2836540
[TBL] [Abstract][Full Text] [Related]
17. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
Fletcher MP; Seligmann BE; Gallin JI
J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of surface receptors for synthetic N-formylated chemotactic oligopeptides by stimulated peripheral blood neutrophils in psoriasis.
Glinski W; Anhalt T; Mansbridge JN
J Invest Dermatol; 1987 Nov; 89(5):523-8. PubMed ID: 3668297
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
Borish L; O'Reilly D; Klempner MS; Rocklin RE
J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
[TBL] [Abstract][Full Text] [Related]
20. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
Daughaday CC; Mehta J; Spilberg I; Atkinson JP
J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
